Early research indicates GLP-1 households are pulling back on food and alcohol purchases more significantly than the average shopper
Tirzepatide deep-dive Tirzepatide is made by Eli Lilly under two brand names: Mounjaro -- weekly injection, FDA-approved for type 2 diabetes in 2022 (doses 2.5 mg through 15 mg) Zepbound -- weekly injection, FDA-approved for chronic weight management in November 2023 [4] The headline trial is SURMOUNT-1: 2,539 adults without diabetes, BMI of 30 or higher (or 27 with a weight-related condition), randomized across three tirzepatide doses (5, 10, 15 mg) versus placebo for 72 weeks
For tirzepatide with its five-day half-life, steady state arrives slightly sooner, around 20-25 days
genetic testing can hint at your probable response, but trial experience remains the gold standard
- Those seeking food that supports liver health and antioxidant activity
Some peoples issues with the Warburg effect or central nervous system dysfunctions may be too severe to exercise until they can better control them through the above-mentioned strategies